In all groups, agents acting on the renin–angiotensin system were the most frequently prescribed treatments and, in general, cardiovascular drugs (antihypertensives, antithrombotic agents, and lipid-modifying agents) were more common in patients with diabetes (with or without HCV infection) compared to HCV+-only patients. This evidence concerns the gene REN and diabetes mellitus.